Sep 12, 2023 / 04:50PM GMT
Eric White Coldwell - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Good afternoon, everyone. My name is Eric Coldwell. I cover pharma distribution and health care services at Baird, and it's our pleasure to have -- I almost said AmerisourceBergen again, Jim, it's just such an old habit; Cencora, with us today. And that is a very recent name change and ticker change. So hopefully, we do a great job of branding and marketing exercises here for the rest of the session.
We have Jim Cleary with us, of course; CFO, Bennett Murphy in Investor Relations. This has been one of our top ideas for a number of years. We got back involved in the drug distribution space in February of 2020. ABC has been either a formal best idea or one of the communicated best ideas ever since that point.
And we have a very long history, I think it's that ABC again, which is -- I was just going to be habit. I'm going to do it until I don't. I don't have a big formal intro, but I wanted to ask you if you wanted to jump in with any initial commentary, Jim, before we get going or
Cencora Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers